Expert Advice 8 May 2019Why It’s Important to “Think Big” When Raising Money for Your Company There are not many people who can say they led one of Europe’s largest biotechs and launched the first approved… May 8, 2019 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 18 Apr 2019Hookipa’s €75M IPO to Fund Vaccines for Viral Infection and Cancer The Austrian biotech Hookipa expects to raise €75M ($84M) in an IPO on the Nasdaq stock exchange to fund the… April 18, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 Feb 2019Austrian Biotech Raises €33.2M to Fund Cancer Vaccines A Series D round of €33.2M ($37.4M) is to help the biotech Hookipa advance the clinical development of therapeutic vaccines… February 28, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jan 2019Austrian Biopharma Reaches First HIV Vaccine Milestone Hookipa Pharma has reached its first milestone in a partnership deal with US-based CAR T pioneers Gilead Sciences to develop… January 3, 2019 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 7 Feb 2018Hookipa CEO “Sleeps Quite Well at Night” with €50M Cash Pile and Cancer Vaccine Progress Did you miss us in Vienna? Here's the first of our two interviews from the Refresh meetup last month: Jörn… February 7, 2018 - 4 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2017Someone’s Popular! Gilead is Just One Big Name Investing in this Vaccine Biotech Gilead has joined a growing list of powerful investors that want to help Hookipa Biotech develop its vaccine technology by… December 14, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 20 Jun 2017Boosting the Immune System with Vaccines to Fight Cancer: A Review Immunotherapies have been taking the biotech world by storm. Among these are cancer vaccines, which are directed at solid tumors… June 20, 2017 - 7 minutesmins - By Diana Kwon Share WhatsApp Twitter Linkedin Email
News and Trends 4 May 2017Solid First-in-Human Results from Vaccine against Birth Defects Hookipa has presented positive data from its first Phase I trial testing its vaccine technology against human cytomegalovirus (hCMV) infections.… May 4, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 3 Jan 201710 Hot European Biotechs to Observe in 2017 🚀 New year, new list: here are the 10 hottest Biotech companies I will watch closely in 2017 and why. This… January 3, 2017 - 5 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 18 Oct 2016€4M Grant for a Cancer Vaccine that could Bench its Competitors Hookipa just secured a huge grant from the Austrian government. The plan is to develop the strongest HPV vaccine ever and… October 18, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 12 Sep 2016Grüßgott, get to Meet 9 exciting Biotechs from Vienna Classical music, the Danube, Schnitzel, and apple strüdel - a typical combination of Vienna. The city has also been at… September 12, 2016 - 6 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jul 2016Former uniQure and Evotec CEO pushes new viral candidate into Clinical Trials Hookipa is starting its first clinical trial for a vaccine against human cytomegalovirus. This is the leading candidate of its… July 21, 2016 - 2 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email